UQCCR Professor Carlos Salomon, in collaboration with Professor Yusuke Yamauchi from the Australian Institute for Bioengineering and Nanotechnology (AIBN), have developed an alternative early detection test for ovarian cancer.
The test can detect the disease at concentration levels 50 times lower than the existing commercial kit — giving clinicians a head start in detecting ovarian cancer earlier and in evaluating the progression of the disease.
To prove this further, we are looking to start a new study in a larger population of women (around 200 women).
